Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
  • Healthcare Stock Insights: Vivus Wins FDA Diet Drug THUMBS UP, StemCells Give BACK
    Vivus Inc. (NASDAQ:VVUS) shares predictably jump, on word that the FDA okayed its weight-loss drug Qnexa/Qsymia on Wednesday, even though they has plummeted just before the announcement. At the same time, shares of Vivus’ competitors Arena ...
    07/18/2012 - 1:00 pm | View Link
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:35 pm | View Link
  • Vivus Wins FDA Approval
    MINYANVILLE ORIGINAL Vivus (VVUS) shareholders got a piece of good news late last week when the Food and Drug Administration approved the ... a decision on market clearance in April but the FDA delayed doing so until July 17. "The majority of the value ...
    04/30/2012 - 12:40 pm | View Link
  • Vivus' Erectile Dysfunction Drug Stendra Wins FDA Approval
    Law360, New York (April 27, 2012, 8:00 PM ET) -- The U.S. Food and Drug Administration on Friday approved Vivus Inc.'s erectile dysfunction pill Stendra, the first erectile dysfunction treatment to be allowed for use in the U.S. in a decade and the first ...
    04/27/2012 - 2:00 pm | View Link
  • Vivus Obesity Pill Wins FDA Panel Nod; NeuroSearch Surges
    Trading in Vivus stock was halted yesterday before the FDA panel vote. NeuroSearch, which is developing tesofensine for obesity, climbed 5.6 percent to 17 kroner and Novo Nordisk, which is studying its Victoza diabetes drug as a weight-loss treatment ...
    02/23/2012 - 8:23 am | View Link
  • More
  • VVUS Key Statistics
    Updated key statistics for VIVUS Inc. - including VVUS margins, P/E ratio, valuation, profitability, company description, and other stock analysis data.
    12/19/2014 - 12:59 am | View Website
  • VVUS Stock Quote
    Updated stock quote for VVUS - including VVUS stock price today, earnings and estimates, stock charts, news, futures and other investing data.
    12/18/2014 - 10:15 pm | View Website
  • VVUS stock quote
    Stock quote for VIVUS, Inc. (VVUS) - Get real-time last sale and extended hours stock prices, company news, charts, and company-specific research tools for VIVUS, Inc ...
    12/17/2014 - 10:30 pm | View Website
  • Regeneron's Eye Drug Eylea Wins Another FDA Approval ...
    Good news flowed in at Regeneron Pharmaceuticals (REGN - Analyst Report) when the FDA cleared the company’s highly successful injectable eye drug for ...
    10/7/2014 - 3:58 pm | View Website
  • FDA Approves New Weight-Loss Drug Contrave
    U.S. regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments. The drug was developed by ...
    09/11/2014 - 5:26 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News